Anvisa aprova segundo medicamento genérico de semaglutida episode artwork

EPISODE · Aug 24, 2026 · 2 MIN

Anvisa aprova segundo medicamento genérico de semaglutida

from Saúde · host CBN

A Agência Nacional de Vigilância Sanitária (Anvisa) aprovou o segundo medicamento genérico de semaglutida do Brasil. Conhecido popularmente como caneta emagrecedora, o remédio pertence à classe dos análogos do GLP-1. O registro foi concedido à Germed Farmacêutica. Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode metadata supplied by the publisher feed · Published Aug 24, 2026

Embed this episode

Ready to play

Anvisa aprova segundo medicamento genérico de semaglutida

0:00 2:45

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Saúde?

This episode is 2 minutes long.

When was this Saúde episode published?

This episode was published on August 24, 2026.

Can I download this Saúde episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!